Literature DB >> 21350319

[Guidelines for the treatment of functional dyspepsia].

Sam Ryong Jee1, Hye Kyung Jung, Byung Hoon Min, Kee Don Choi, Poong Lyul Rhee, Young Woo Kang, Sang In Lee.   

Abstract

Functional dyspepsia (FD) is defined as the presence of symptoms thought to originate in the gastroduodenal area, in the absence of any organic, systemic, or metabolic disease that is likely to explain the symptoms. Based on the available evidence and consensus opinion, thirteen consensus statements for the treatment of FD were developed using the modified Delphi approach. Proton pump inhibitor, prokinetics, and histamine 2 receptor antagonists are effective for the treatment of FD. Mucosal protecting agents, fundus relaxant, and drugs for visceral hypersensitivity can improve symptoms in FD. Antacids and antidepressants may help improving symptoms in FD. Comparing endoscopy with 'test and treat' of Helicobacter pylori, endoscopy may be more effective initial strategy for managing patients with FD in Korea given high incidence of gastric cancer and low cost of endoscopy. Helicobacter pylori eradication can be one of the therapeutic options for patients with FD. Psychotherapy is effective for those who have severe symptoms and refractoriness. Further studies are strongly needed to develop better treatment strategies for Korean patients with FD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350319     DOI: 10.4166/kjg.2011.57.2.67

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  7 in total

Review 1.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

2.  Availability of tongue diagnosis system for assessing tongue coating thickness in patients with functional dyspepsia.

Authors:  Juyeon Kim; Jiyoung Son; Seungwon Jang; Dong-Hyun Nam; Gajin Han; Inkwon Yeo; Seok-Jae Ko; Jae-Woo Park; Bongha Ryu; Jinsung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-15       Impact factor: 2.629

Review 3.  The Korean Perspective of Helicobacter pylori Infection: Lessons from Japan Policy to Prevent Gastric Cancer.

Authors:  Sooyeon Lee; Jong-Min Park; Sang-Ho Park; Eun-Hee Kim; Ki Baik Hahm
Journal:  J Cancer Prev       Date:  2013-06

4.  Feasibility study of structured diagnosis methods for functional dyspepsia in Korean medicine clinics.

Authors:  Jeong Hwan Park; Soyoung Kim; Jae-Woo Park; Seok-Jae Ko; Sanghun Lee
Journal:  Integr Med Res       Date:  2017-10-17

Review 5.  Current status of functional dyspepsia in Korea.

Authors:  Hyuk Lee; Hye-Kyung Jung; Kyu Chan Huh
Journal:  Korean J Intern Med       Date:  2014-02-27       Impact factor: 2.884

6.  A Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus reuteri for Chronic Functional Abdominal Pain in Children.

Authors:  Kambiz Eftekhari; Zahra Vahedi; Mojtaba Kamali Aghdam; Diana Noemi Diaz
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

7.  Efficacy and Safety of DWJ1252 Compared With Gasmotin in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study.

Authors:  Jin Hwa Park; Kang Nyeong Lee; Oh Young Lee; Myung-Gyu Choi; Hyunsoo Chung; Suck-Chei Choi; Nayoung Kim; Hyojin Park; In-Kyung Sung; Chong Il Sohn; Sam Ryong Jee; Jae Young Jang; Poong-Lyul Rhee; Moo In Park; Joong Goo Kwon; Kyung Sik Park; Kwang Jae Lee; Joon Seong Lee
Journal:  J Neurogastroenterol Motil       Date:  2021-01-30       Impact factor: 4.924

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.